Skip to main content
. 2021 Sep 14;11(9):152. doi: 10.1038/s41408-021-00547-8

Fig. 3. Emerging therapeutic targets from the immune and inflammasome pathway in MDS.

Fig. 3

The figure depicts the various biomolecules from the inflammasome pathway that are targeted by the novel therapeutic agents in MDS and AML.